SEC Filing Update: #OVID Ovid Therapeutics Inc. : $2.80

Sector: Healthcare | YTD: 🔼+ 59.09% The SEC disclosed Today (14-AUG-2026) that BALYASNY ASSET MANAGEMENT LLC has INCREASED #OVID Shares by 32.49% 🟢 * Previous Holdings: 7.03M Shares * Current Holdings: 9.31M Shares * Increase+2.28M * Increased(%)+32.49% * Ownership: 4.99% * Estimated Investment Value: $5.98M https://www.thinksabio.com/reports/isr/OVID Institutional ownership in #OVID has been steadily rising over the past 4 quarters in Shares: Q2 2025: 35.97M Q3 2025: 36.21M Q4 2025: 61.87M Q1 2026: 105.07M The quarterly average prices of #OVID: Q3 2025: $0.87 Q4 2025: $1.54 Q1 2026: $1.79 📌 Institutional activity in the last 30 days for #OVID: • AFFINITY ASSET ADVISORS, LLC – Increased holdings by 4,999,166 shares (13-AUG-2026) • BLACKROCK INC – Increased holdings by 9,289,389 shares (29-JUL-2026)